Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-047880

Director bought 82,052 shares at an average $1.32 ($107,898)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lamond David Director 2023-08-30 Purchase +41,026 $1.31 $53,744 2,138,135 I: show line 1 in the form
Lamond David Director 2023-08-31 Purchase +41,026 $1.32 $54,154 2,179,161 I: show line 2 in the form
Open-market purchases · 82,052 sh · avg $1.32 · $107,898
Loading xslF345X05/doc4.xml…